| 104728-1 | Base excess standard (Venous Blood) | CHEM |
| 104729-9 | Medication exceptional safety override Narrative | MEDS |
| 10473-7 | Chymotrypsin Ag (Tissue, qualitative, immune stain) | PATH |
| 104730-7 | Influenza virus A H3 RNA in Specimen (qualitative, molecular genetics method) | MICRO |
| 104731-5 | Clostridioides difficile toxin genes (Stool, qualitative, molecular genetics method) | MICRO |
| 104732-3 | HIV 1 Ab band pattern | MICRO |
| 104733-1 | Maximum number of administrations | MEDS |
| 104734-9 | Streptococcus.beta-hemolytic in Specimen (qualitative) | MICRO |
| 104735-6 | Influenza virus B RNA in Specimen (qualitative, molecular genetics method) | MICRO |
| 104736-4 | Clinician guidance Medication Narrative | MEDS |
| 104737-2 | Human metapneumovirus RNA in Specimen (qualitative, molecular genetics method) | MICRO |
| 104738-0 | Hemoglobin from gastrointestinal lower (Stool, qualitative) | HEM/BC |
| 104739-8 | Protein Fractions Narrative (Urine) | CHEM |
| 10474-5 | Collagen type 4 Ag (Tissue, qualitative, immune stain) | PATH |
| 104740-6 | Prostate cancer risk | CHEM |
| 104741-4 | Hepatitis C virus Ab Signal/Cutoff | MICRO |
| 104742-2 | Ova and parasites identified in Specimen | MICRO |
| 104743-0 | Epstein Barr virus DNA in Specimen (molecular genetics method) | MICRO |
| 104744-8 | Respiratory syncytial virus RNA in Specimen (qualitative, molecular genetics method) | MICRO |
| 104745-5 | N-nortramadol (Urine) | DRUG/TOX |
| 104746-3 | Medication stop criteria | MEDS |
| 104747-1 | Medication purpose Narrative | MEDS |
| 104748-9 | Medication order stop | MEDS |
| 104749-7 | Review criteria Narrative | MEDS |
| 10475-2 | Corticotropin Ag (Tissue, qualitative, immune stain) | PATH |
| 104750-5 | Ovalocytes (qualitative) | HEM/BC |
| 104751-3 | Smudge cells (qualitative) | HEM/BC |
| 104752-1 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA in Cervix (qualitative, molecular genetics method) | MICRO |
| 104753-9 | Burr cells (qualitative) | HEM/BC |
| 104754-7 | Polychromasia (qualitative) | HEM/BC |
| 104755-4 | Hepatitis C virus RNA (molecular genetics method) | MICRO |
| 104756-2 | Order identifier | CLIN |
| 104757-0 | Staphylococcus aureus DNA in Specimen (qualitative, molecular genetics method) | MICRO |
| 104758-8 | Gardnerella vaginalis DNA in Vaginal fluid (qualitative, molecular genetics method) | MICRO |
| 104759-6 | Dohle body (qualitative) | HEM/BC |
| 10476-0 | Desmin Ag (Tissue, qualitative, immune stain) | PATH |
| 104760-4 | Cytomegalovirus DNA in Specimen (qualitative, molecular genetics method) | MICRO |
| 104761-2 | Poikilocytosis (qualitative) | HEM/BC |
| 104762-0 | HIV 1 RNA (molecular genetics method) | MICRO |
| 104763-8 | Medication dispense instructions Medication Narrative | MEDS |
| 104764-6 | Base excess | HEM/BC |
| 104765-3 | Neisseria gonorrhoeae DNA in Specimen (qualitative, molecular genetics method) | MICRO |
| 104766-1 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA in Cervix (qualitative, molecular genetics method) | MICRO |
| 104767-9 | Salmonella sp in Isolate (sequencing) | MICRO |
| 104768-7 | NCBI BioProject identifier in Specimen | MICRO |
| 104769-5 | NCBI sequence read archive number in Specimen | MICRO |
| 10477-8 | Enolase.neuron specific Ag (Tissue, qualitative, immune stain) | PATH |
| 104770-3 | NCBI sequence read experiment (SRX) number in Specimen | MICRO |
| 104771-1 | NCBI sequence read Run (SRR) number in Specimen | MICRO |
| 104772-9 | Salmonella sp serotype in Isolate (sequencing) | MICRO |